TrialClinical and experimental immunology2015

Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo.

Y M El-Sherbiny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.